Among them, CCL2 is the most potent activator of CCR2 signaling, and the upregulation of CCR2 by CCL2 is associated with cancer metastasis, relapse, and inflammatory diseases in the central nervous system, including multiple sclerosis, Alzheimer’s disease and ischemic stroke14,15. Here, CCL2 is linked to early-onset autosomal dominant Alzheimer disease.